 |
THE DARK REPORT: RECENT ARTICLE ARCHIVE - All Rights Reserved.
CEO SUMMARY: Recent developments in breast cancer
testing are leading to changes in pathology. Oncologists and
pathologists have issued new guidelines regarding HER2 testing
and new research suggests changes may be coming for
estrogen-receptor testing as well. For the first time, the new
guidelines require a certain level of testing and new procedures
for pre-analytical processing.
Download full article (PDF) New Rules to Boost
Cancer Test Accuracy
Copyright 2007 ©DarkReport.com All rights reserved
worldwide Privacy Policy Statement